Most Recent Articles by Christina Bennett, MS
HPV gene signature was associated with outcomes in patients with HPV-related oropharyngeal cancers and could become a prognostic biomarker.
Researchers propose a way to determine the long-term benefit of immune checkpoint inhibitors that differs from the approach in the ASCO Value Framework.
A review article highlighted the racial disparities in head and neck cancer incidence and identified how this relates to HPV infection.
Administration of vaccines via the unconventional intravenous route conferred greater antitumor activity in mice than the traditional subcutaneous route.
Patients in close contact with the health care system are more likely to get diagnosed with skin cancer, suggesting the possibility of detection bias in studies.
More Articles by Christina Bennett, MS
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Radical Prostatectomy Compared With Watchful Waiting in Localized Prostate Cancer
- Immunotherapy in Glioblastoma: Peaks and Pits
- Treatment Guidelines in Cancer: Assessing Industry Influence on Recommendations
- American Society of Breast Surgeons Recommends Genetic Testing for All Patients With Breast Cancer
- No Benefit Seen From HSCT in Hypodiploid B-ALL
- Patients With CP-CML Deemed Less Likely to Continue Taking Generic Imatinib
- Opinion: Understanding the FDA's Take on Cannabidiol